Michael D. Schneider
Directeur/Membre du Conseil chez The Medical Research Council
Postes actifs de Michael D. Schneider
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Directeur/Membre du Conseil | 12/07/2011 | - |
Historique de carrière de Michael D. Schneider
Anciens postes connus de Michael D. Schneider
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| British Heart Foundation | Corporate Officer/Principal | 14/05/2010 | - |
| Baylor College of Medicine | Corporate Officer/Principal | 01/01/1984 | - |
The National Heart & Lung Institute
 The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services The National Heart & Lung Institute provided medical educational services. The company was headquartered in London, the United Kingdom. | Corporate Officer/Principal | 14/05/2010 | - |
Kardia Therapeutics, Inc.
 Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 01/01/2002 | - |
| Fondateur | 17/08/2009 | - |
Formation de Michael D. Schneider
| University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 4 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 1 |
Sectorielle
| Commercial Services | 4 |
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kardia Therapeutics, Inc.
Kardia Therapeutics, Inc. BiotechnologyHealth Technology Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX. | Health Technology |
The National Heart & Lung Institute
The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services The National Heart & Lung Institute provided medical educational services. The company was headquartered in London, the United Kingdom. | Commercial Services |
| British Heart Foundation | Commercial Services |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
- Bourse
- Insiders
- Michael D. Schneider
- Expérience
